Efficacy and Safety of MG in the Patients With Alcoholic Fatty Liver Disease and Alcoholic Hepatitis

Clinical trial NCT02019056 · COMPLETED

Trial details

NCT number: NCT02019056
Sponsor: PharmaKing
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Alcoholic Fatty Liver Disease Alcoholic Hepatitis

Start date: 2010-11-01
Primary completion: 2014-12-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.